Cerevel Therapeutics Holdings, Inc.
News
AbbVie Completes Acquisition of Cerevel Therapeutics
PR Newswire AbbVie Completes Acquisition of Cerevel Therapeutics AbbVie Completes Acquisition of Cerevel Therapeutics PR Newswire NORTH CHICAGO, Ill., Aug. 1, 2024 Cerevel's clinical-stage assets complement...\n more…
Vanguard Group Inc. Purchases 88,941 Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
Zolmax Vanguard Group Inc. lifted its position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) by 1.2% in the 1st quarter, according to its most recent Form 13F filing with the...\n more…
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Director N Anthony Coles Sells 25,000 Shares
Zolmax Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Get Free Report) Director N Anthony Coles sold 25,000 shares of the company's stock in a transaction that occurred on Monday, July 1st. The shares...\n more…
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Director N Anthony Coles Sells 25,000 Shares
Ticker Report Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Get Free Report) Director N Anthony Coles sold 25,000 shares of Cerevel Therapeutics stock in a transaction dated Monday, July 1st. The stock was...\n more…
Vanguard Group Inc. Raises Stock Holdings in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
Ticker Report Vanguard Group Inc. increased its position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) by 15.8% during the 4th quarter, according to the company in its most recent Form 13F...\n more…